Congratulations to the trial team and NOX. Great results.
https://meetinglibrary.asco.org/record/183361/abstract
It would be good to see cohort splits, but here's a comparison between the interim results:
Interim:
Median PSA PFS was 6.5 months
62.5% PSA response > 50%
Median Overall Survival 17.1 months
Final:
Median PSA PFS was 7.5 months
61% PSA response > 50%
Median overall survival was 19.7 months
LuPIN abstract, page-5
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $5.496K | 45.98K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 74793 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 10550 | 2 |
View Market Depth
| Last trade - 10.06am 02/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |